Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
November 2012 Volume 28 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November 2012 Volume 28 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma

  • Authors:
    • Ken-Ichi Okada
    • Hiroshi Kijima
    • Toshihide Imaizumi
    • Kenichi Hirabayashi
    • Masahiro Matsuyama
    • Naoki Yazawa
    • Shoichi Dowaki
    • Kosuke Tobita
    • Yasuo Ohtani
    • Makiko Tanaka
    • Sadaki Inokuchi
    • Hiroyasu Makuuchi
  • View Affiliations / Copyright

    Affiliations: Department of Surgery, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan, Department of Pathology, Hirosaki University School of Medicine, Hirosaki, Aomori 036-8562, Japan, Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan, Department of Critical Care and Emergency Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan
    Copyright: © Okada et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 1531-1536
    |
    Published online on: August 10, 2012
       https://doi.org/10.3892/or.2012.1971
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

We have previously classified wall invasion patterns of gallbladder carcinoma (GBC) cases into two groups, i.e., the infiltrative growth type (IG type) and destructive growth type (DG type). The DG type was significantly associated with poor differentiation, aggressive infiltration and decreased postoperative survival in terms of its histological differentiation, lymphatic invasion, venous invasion, lymph node status, neural invasion and mode of subserosal infiltration. In the present study, we analyzed 42 surgically-resected subserosal invasive gallbladder adenocarcinomas, invading the perimuscular connective tissue (pT2). The cumulative 5-year survival rate in the series was 48.7%. Lymphatic invasion (p=0.021), venous invasion (p=0.020), mode of subserosal infiltration (p<0.001), histological differentiation (p=0.030) and biliary infiltration (p=0.007) were noted, respectively, at a significantly higher incidence in more aggressive infiltration or poor differentiation in the DG type. The cumulative 5-year survival rate of curative resection cases was lower in patients with the DG type than in those with the IG type (68.9 versus 20.2%, respectively, p=0.006, log-rank test). On Cox's proportional hazard regression modeling, the low degree of venous/perineural invasion and IG type of wall invasion pattern were associated with a significant improvement in overall survival. Our data suggest that the wall invasion pattern is an independent predictor of survival in subserosal invasive GBC. Regarding the clinical application of our concept, on the classification of patients with subserosal invasive GBC based on a combination of the wall invasion pattern and lymph node status, the overall survival rate in patients with the DG type and/or N2 metastasis (n=21) was lower than in patients with the IG type and N0, 1 metastasis (n=21) (p=0.0023, log-rank test). The wall invasion pattern could contribute to decision-making concerning curative resection for subserosal invasive GBC.

Introduction

We have classified the wall invasion pattern of gallbladder carcinoma (GBC) into two groups, i.e., the infiltrative growth type (IG type) and destructive growth type (DG type) (1). The DG type was significantly associated with poor differentiation, aggressive infiltration, and decreased postoperative survival in histological differentiation, lymphatic invasion, venous invasion, lymph node status, neural invasion, and mode of subserosal infiltration. Therefore, the classification of the IG/DG growth pattern is thought to be a useful indicator of the local aggressiveness of GBC. There has been no definition or classification of the wall invasion pattern, and it was defined mainly based on the invasive phenomenon through the muscle layer. We also demonstrated that the wall invasion pattern was correlated with the overall aggressiveness of cancer, i.e., cell proliferation and local aggressiveness of cancer, such as the stromal infiltration of GBC using an immunohistochemical procedure (2). High-grade cell proliferation employing the Ki-67 labeling index (Ki-67 LI) and invasiveness with stromal laminin-5 γ2 chain staining were significantly correlated with an aggressive wall invasion pattern indicating the DG type of GBC. In this study, we analyzed the prognostic value of the wall invasion pattern at a clinically significant depth of tumor invasion, i.e., the subserosal layer.

From the viewpoints of surgical pathology and anatomy, it is sometimes difficult to resect advanced GBC radically (3). There is controversy regarding the surgical indication, such as partial resection of the liver, bile duct resection, and pancreatoduodenectomy for dissecting regional lymph nodes (4–8). Since preoperative evaluation of the tumor spread of subserosa-invasive GBC was difficult, the risk of excessive or inadequate surgery is relatively high. Therefore, it is important to reconsider the surgical procedure to ensure an appropriate operation avoiding oversurgery. Previous studies reported that the presence of lymph node metastases represented the main marker of a poor prognosis (9–12). Intraoperative frozen sections provide important information on lymph node metastasis in surgery. In addition, we propose the clinical use of the wall invasion pattern as a new prognostic predictor which is also available using ordinary hematoxylin-eosin sections. Classification according to the wall invasion pattern and degree of lymph node metastasis would be helpful to re-examine the necessity of an additional surgical procedure in or after the surgery.

Materials and methods

Gallbladder tissue specimens

All tissue specimens were obtained on the surgical resection of gallbladder adenocarcinomas at Tokai University Hospital. The subjects were 42 patients (24 men and 18 women; age range 40–93 years; mean age 65.4±10.7 years) with gallbladder tumors invading the subserosal layer, i.e., the perimuscular connective tissue (pT2), at surgery. The stages of GBC were based on the TNM classification. The median postoperative follow-up duration was 852.5 (332.0–2,027.8) days.

Histological examination

The gallbladder tissue specimens for histological analysis were rapidly fixed in 10% buffered formalin for 24–48 h and routinely embedded in paraffin. Tumor invasion was examined using 4 μm sections stained with hematoxylin and eosin. The degree of venous invasion was classified as: v0, no venous invasion; v1+, minimal venous invasion, i.e., 1 or 2 foci of venous invasion in one histological section; v2+, moderate venous invasion, i.e., 3 or 4 foci; and v3+, marked venous invasion with ≥5 foci. The degree of lymphatic invasion was classified as: ly0, no lymphatic invasion; ly1+, mild lymphatic invasion, ly2+, moderate lymphatic invasion; and ly3+, marked lymphatic invasion. The degree of perineural invasion was classified as: ne0, no perineural invasion; ne1+, mild perineural invasion; ne2+, moderate perineural invasion; and ne3+, marked perineural invasion. The mode of subserosal infiltration was classified into three groups, according to the General Rules for Gastric Cancer Study of the Japanese Gastric Cancer Association (13), i.e., INF alpha α), a cancer nest showing expansive growth and presenting a clear borderline between itself and adipose tissue; INF beta (β), growth and invasive patterns intermediate of those of α and γ; and INF gamma (γ): scirrhous growth, a cancer nest showing invasive growth, while the borderline between the tumor and adipose tissue is unclear. The degree of biliary invasion was classified as: binf0, no invasion to the hepatoduodenal ligament; binf1, uncertain invasion to the hepatoduodenal ligament; binf2, mild invasion to the hepatoduodenal ligament; or binf3, moderate to marked invasion to the hepatoduodenal ligament.

Definition and histological identification of invasion pattern

The following terminology was used to define and classify the two patterns of invasion through the muscle layer. Infiltrative growth (IG) type: cancer cells show infiltrative growth in the muscle layer (through the intermuscular space) without muscle layer destruction (Fig. 1A and C) (1). Destructive growth (DG) type: cancer cells show massive growth with destruction of the muscle layer (Fig. 1B and D) (1). The cases showing both DG and IG components were classified as the DG type because aggressive growth patterns were present.

Figure 1

A scheme and microscopic findings of gallbladder carcinoma invasion. IG type (A and C), cancer cells show infiltrative growth in the muscle layer (through the intermuscular space) without muscle layer destruction. DG type (B and D), cancer cells invade the subserosal layer with destruction of the muscle layer. The DG type was accompanied by a stromal desmoplastic reaction with activated fibroblasts and dense collagen fibers, which were aniline blue-positive (E). The IG type revealed a less pronounced reaction of desmoplasia, weakly positive for aniline blue (F). (A and B) Schematic of invasion; (C and D) Hematoxylin-eosin staining; (E and F) Azan staining.

Azan staining was helpful for distinguishing the DG from the IG type of GBC. The DG type usually showed aggressive growth, and included a stromal desmoplastic reaction with activated fibroblasts and dense collagen fibers, which were aniline blue-positive with Azan staining (Fig. 1F). The IG type revealed a lower-level reaction of desmoplasia, which was weakly positive for aniline blue (Fig. 1E).

Statistical analysis

Descriptive statistical analyses were employed to examine the demographic characteristics of the study population. Data are expressed as means ± SD and medians (25th and 75th percentiles). The baseline characteristics, disease, and pathological variables were compared between patients with the IG and DG types by means of the χ2 test for continuous and categorical variables. Univariate analyses (χ2 test) were primarily used for selecting variables on the basis of a p<0.05. The significant variables in univariate analyses and clinically significant factors were subjected to Cox’s proportional hazard regression modeling to assess the effect that independent covariates had on the dependent variable of survival. Odds ratios (ORs) and their 95% confidence intervals (CIs) were used to assess the independent contributions of significant factors. A p<0.05 was considered to indicate significance.

Survival times were measured from the date of surgery, and death from all causes (without differentiating between deaths resulting from GBC or other causes) was taken as the outcome. Survival curves were traced with the Kaplan-Meier method, and the comparison of survival curves was carried out using the log-rank test. All analyses were performed using the statistical software package SPSS II (version 11.0; SPSS, Tokyo, Japan).

Results

Of the 42 subserosa-invasive GBCs (pT2), 24 (57.1%) cases showed the IG type and 18 (42.9%) the DG type. Well to moderately differentiated adenocarcinoma was the most frequent histological type (85.7%). Poorly differentiated adenocarcinoma and other histological types such as signet ring cell carcinoma and adenosquamous cell carcinoma were also observed. We analyzed the relationship between the wall invasion patterns through the muscle layer and clinicopathological features (Table I). Lymphatic invasion (p=0.021), venous invasion (p=0.020), mode of subserosal infiltration (p<0.001), histological differentiation, (p=0.030) and biliary infiltration (p=0.007) were noted, respectively, at a significantly higher incidence in more aggressive infiltration or poor differentiation in the DG type. In addition, cases with the DG type tended to show a higher incidence of neural invasion (p=0.094) and lymph node metastasis (p=0.103). The overall survival rate in the series was 48.7%. Fig. 2 shows the survival curves of patients with each wall invasion pattern. The cumulative 5-year survival rate of curative resection cases was lower in patients with the DG type than in those with the IG type (20.2 versus 68.9%, respectively, p=0.006, log-rank test).

Figure 2

Survival curves of gallbladder cancer patients with subserosal invasion according to the wall invasion pattern. Patients with the DG type (dotted line, n=18) showed a significantly poorer prognosis compared to those with the IG type (solid line, n=24; p=0.006, log-rank test).

Table I

The invasion pattern and clinicopathological features of human subserosa-invasive gallbladder cancer.

Table I

The invasion pattern and clinicopathological features of human subserosa-invasive gallbladder cancer.

Invasion pattern

Clinicopathological featuresNo. of patientsIGDGRate of DG pattern (%)p-value χ2 test
Histological differentiation
 Well, mod.36231336.10.030
 Poor, other61583.3
Lymphatic invasion
 ly0, 1+2920931.00.021
 ly2+, 3+134969.2
Venous invasion
 v0, 1+2719829.60.020
 v2+, 3+1551066.7
Nodal status
 pN0, 133211236.40.103
 pN293666.7
Neural invasion
 ne0, 1+2718933.30.094
 ne2+, 3+156960.0
Subserosal infiltration
 INFα, β2922724.1<0.001
 INFγ1321184.6
Biliary invasion
 binf0, 132221031.30.007
 binf2, 3102880.0
 Overall42241842.9

[i] IG, infiltrative growth type; DG, destructive growth type; ly, degree of lymphatic invasion; v, venous invasion; ne, neural invasion; binf, biliary invasion. INF α, β and γ, the mode of subserosal infiltration; N, the lymph node status based on the TNM classification. See Materials and methods.

To define the significance of prognostic factors, a Cox’s proportional hazard regression model was designed to assess factors which were significant on univariate analysis. In this model, the low degree of venous/perineural invasion (v0,1+/pn0,1+) and the IG type of wall invasion pattern were associated with a significant improvement in overall survival (Table II).

Table II

Cox’s proportional hazards model of human subserosa-invasive gallbladder cancer.

Table II

Cox’s proportional hazards model of human subserosa-invasive gallbladder cancer.

FactorRisk ratiop-value95% confidence interval
Sex0.5660.2800.201–1.589
Venous invasion0.1540.0420.025–0.931
Perineural invasion20.0790.0022.959–136.241
Invasion pattern3.6910.0201.232–11.058

All the cases of subserosa-invasive GBC were categorized into two groups in terms of the wall invasion pattern and lymph node status, and their survival rates were compared using the Kaplan-Meier method and log-rank test. The overall survival rate in patients with the DG type and/or N2 metastasis (n=21) was lower than those with the IG type and N0, 1 metastasis (n=21) (p=0.0023, log-rank test) (Fig. 3).

Figure 3

Survival rate of gallbladder cancer patients grouped according to the wall invasion pattern and degree of lymph node metastasis. Patients with the DG type and/or N2 metastasis (dotted line, n=21) showed a shorter survival than those with the IG type and N0, 1 metastasis (solid line, n=21; p=0.0023, log-rank test).

Discussion

The radical resection of advanced GBC is sometimes difficult because of frequent lymph node metastasis. In this study, we reviewed 42 surgically resected cases of GBC to clarify the relationship between the wall invasion pattern and clinicopathological features, especially in subserosa-invasive GBC. Lymphatic invasion, venous invasion, distant lymph node metastases, poor differentiation, subserosal scirrhous infiltration (INFγ), and biliary infiltration were more frequently detected in the DG type cases, compared with the IG type cases. This is the first report to describe the relationship between the wall invasion pattern and clinicopathological features of subserosa-invasive GBC.

The layers of the gallbladder wall include the surface epithelium, lamina propria, smooth muscle, perimuscular subserosal connective tissue, and serosa, but they lack the muscularis mucosae and submucosa. The smooth muscle layer consists of loosely arranged bundles of muscle fibers, and is thin compared with other parts of the digestive tract (14,15). Therefore, GBCs can easily invade the subserosal layer through the smooth muscle layer, and show frequent vascular permeation and perineural invasion. Our previous study demonstrated that the wall invasion pattern through the muscle layer is correlated with histological aggressiveness and the survival rate of patients with GBC. The cases in our previous study included not only pT2 GBCs (subserosa-invasive GBCs) but also pT3-4 GBCs together. The bias affected by the depth of tumor invasion in the afore-mentioned clinicopathological relationship could not be excluded. In this study, we clarified that our concept was adequate, according to the greater significance at the same tumor invasion depth, i.e., the subserosal layer is the critical depth both clinically and histologically.

Most GBCs are adenocarcinomas that exhibit the well-differentiated type in the mucosal layer whilst growing laterally and superficially, but display the moderately to poorly differentiated type in the gallbladder wall; therefore, advanced GBCs usually show invasive growth with a desmoplastic reaction, especially from the muscle to subserosal layer (16–22). We propose that the DG type is associated with a more intensive desmoplastic reaction than the IG type; i.e., DG and IG types showed different wall invasion patterns throughout the muscle layers, as well as different subserosal stromal desmoplastic reactions of GBC.

Finally, we discuss the clinical applications of the concept we demonstrated in this study. Surgeons try to perform a potentially curative resection for advanced GBC. However, the true benefits of these radical resections have not been completely established because long-term survivors of advanced GBC are limited. Radical surgery should improve not only survival in early GBC, but should also promote long-term benefits in advanced GBC, which shows high mortality and morbidity. Previous studies have reported the importance of radical lymph node dissection for GBC, and many surgeons have encountered cases in which lymph node dissection improved survival. However, we have encountered cases showing a poor subserosa-invasive GBC prognosis even after radical surgery with lymph node dissection regardless of resection of the other organs, such as the bile duct and liver (6–12). The wall invasion pattern of GBC is easily diagnosed using ordinary hematoxylin-eosin sections, and is applicable to intraoperatively frozen sections. Our data clarified that the wall invasion pattern was an independent predictor of survival in subserosa-invasive GBC, i.e., cases of the DG type and/or N2 metastasis showed a significantly poorer prognosis than those of the IG type and N0, 1 metastasis. Therefore, the wall invasion pattern could contribute to decision-making concerning curative resection for advanced GBC (4,5,23–25).

In conclusion, our study provided evidence to support the concept of a wall invasion pattern in subserosa-invasive GBC. The DG invasion pattern is an indicator of a high malignant potential and indirectly worsens the prognosis of patients with gallbladder adenocarcinoma. To reduce the mortality rate after surgery, we can indicate cases with the IG type and N0, 1 metastasis for radical resection in subserosa-invasive GBC.

References

1 

Okada K, Kijima H, Imaizumi T, Hirabayashi K, Matsuyama M, Yazawa N, Oida Y, Dowaki S, Tobita K, Ohtani Y, Tanaka M, Inokuchi S and Makuuchi H: Wall-invasion pattern correlates with survival of patients with gallbladder adenocarcinoma. Anticancer Res. 29:685–691. 2009.PubMed/NCBI

2 

Okada K, Kijima H, Imaizumi T, Hirabayashi K, Matsuyama M, Yazawa N, Oida Y, Dowaki S, Tobita K, Ohtani Y, Tanaka M, Inokuchi S and Makuuchi H: Stromal laminin-5gamma2 chain expression is associated with the wall-invasion pattern of gallbladder adenocarcinoma. Biomed Res. 30:53–62. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Kimura W, Nagai H, Kuroda A and Morioka Y: Clinicopathologic study of asymptomatic gallbladder carcinoma found at autopsy. Cancer. 64:98–103. 1989. View Article : Google Scholar : PubMed/NCBI

4 

Kokudo N, Makuuchi M, Natori T, Sakamoto Y, Yamamoto J, Seki M, Noie T, Sugawara Y, Imamura H, Asahara S and Ikari T: Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 138:741–750. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Chijiiwa K, Nakano K, Ueda J, Noshiro H, Nagai E, Yamaguchi K and Tanaka M: Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg. 192:600–607. 2001. View Article : Google Scholar : PubMed/NCBI

6 

de Aretxabala X, Roa I, Burgos L, Losada H, Roa JC, Mora J, Hepp J, Leon J and Maluenda F: Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer. J Gastrointest Surg. 10:186–192. 2006.PubMed/NCBI

7 

Kosuge T, Sano K, Shimada K, Yamamoto J, Yamasaki S and Makuuchi M: Should the bile duct be preserved or removed in radical surgery for gallbladder cancer? Hepatogastroenterology. 46:2133–2137. 1999.PubMed/NCBI

8 

Shimizu Y, Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Kato A and Miyazaki M: Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery. 136:1012–1017. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Tsukada K, Kurosaki I, Uchida K, Shirai Y, Oohashi Y, Yokoyama N, Watanabe H and Hatakeyama K: Lymph node spread from carcinoma of the gallbladder. Cancer. 80:661–667. 1997. View Article : Google Scholar : PubMed/NCBI

10 

Nagakura S, Shirai Y, Yokoyama N and Hatakeyama K: Clinical significance of lymph node micrometastasis in gallbladder carcinoma. Surgery. 129:704–713. 2001. View Article : Google Scholar : PubMed/NCBI

11 

Sasaki E, Nagino M, Ebata T, Oda K, Arai T, Nishio H and Nimura Y: Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg. 244:99–105. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Shirai Y, Wakai T and Hatakeyama K: Radical lymph node dissection for gallbladder cancer: indications and limitations. Surg Oncol Clin North Am. 16:221–232. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Classification of gastric carcinoma - 2nd English edition. Gastric Cancer. 1:10–24. 1998. View Article : Google Scholar : PubMed/NCBI

14 

Albores-Saavedra J, Henson DE and Sobin LH: The WHO Histological Classification of Tumors of the Gallbladder and Extrahepatic Bile Ducts. A commentary on the second edition. Cancer. 70:410–414. 1992. View Article : Google Scholar : PubMed/NCBI

15 

Albores-Saavedra J, Henson DE and Klimstra DS: Tumors of the Gallbladder, Extrahepatic Bile Ducts and Ampulla of Vater. Atlas of Tumor Pathology. 3rd Series, Fasc. 27. Armed Forces Institute of Pathology; Washington, DC: pp. 37–111. 2000

16 

Nishime C, Ohnishi Y, Suemizu H, Tamaoki N, Suematsu M, Oida Y, Yamazaki H, Nakamura M, Ueyama Y and Kijima H: Gallbladder small cell carcinoma Xenograft established by serial transplantation in nude mice. Anticancer Res. 26:79–83. 2006.PubMed/NCBI

17 

Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, et al: Clinicopathological significance of sialyl Lex expression in human gallbladder carcinoma. Oncol Rep. 11:1139–1143. 2004.PubMed/NCBI

18 

Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S and Makuuchi H: MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis. Oncol Rep. 8:485–489. 2001.PubMed/NCBI

19 

Kijima H, Kashiwagi H, Dowaki S, Ohtani Y, Tobita K, Matsubayasi H, Ajioka Y, Watanabe H, Tsuchida T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M and Makuuchi H: Stromal sialyl Le(a) expression is correlated with vascular invasion of human gallbladder adenocarcinoma. Int J Oncol. 17:55–60. 2000.PubMed/NCBI

20 

Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Tsukui M, Tanaka Y, Matsubayasi H, Tsuchida T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Tajima T and Makuuchi H: DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion. Int J Oncol. 16:455–459. 2000.PubMed/NCBI

21 

Dowaki S, Kijima H, Kashiwagi H, Ohtani Y, Tobita K, Tsukui M, Tanaka Y, Tazawa K, Matsubayashi H, Tsuchida T, et al: CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinoma. Int J Oncol. 16:49–53. 2000.PubMed/NCBI

22 

Ohtani Y, Kijima H, Dowaki S, Kashiwagi H, Tobita K, Tsukui M, Tanaka Y, Tsuchida T, Tokunaga T, Yamazaki H, et al: Stromal expression of thrombospondin-1 is correlated with growth and metastasis of human gallbladder carcinoma. Int J Oncol. 15:453–457. 1999.PubMed/NCBI

23 

Nakata T, Kobayashi A, Miwa S, Soeda J and Miyagawa S: Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma. World J Surg. 31:155–161. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Kaneoka Y, Yamaguchi A, Isogai M, Harada T and Suzuki M: Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation. World J Surg. 27:260–265. 2003. View Article : Google Scholar : PubMed/NCBI

25 

Kayahara M and Nagakawa T: Recent trends of gallbladder cancer in Japan: an analysis of 4770 patients. Cancer. 110:572–580. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Okada K, Kijima H, Imaizumi T, Hirabayashi K, Matsuyama M, Yazawa N, Dowaki S, Tobita K, Ohtani Y, Tanaka M, Tanaka M, et al: Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma. Oncol Rep 28: 1531-1536, 2012.
APA
Okada, K., Kijima, H., Imaizumi, T., Hirabayashi, K., Matsuyama, M., Yazawa, N. ... Makuuchi, H. (2012). Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma. Oncology Reports, 28, 1531-1536. https://doi.org/10.3892/or.2012.1971
MLA
Okada, K., Kijima, H., Imaizumi, T., Hirabayashi, K., Matsuyama, M., Yazawa, N., Dowaki, S., Tobita, K., Ohtani, Y., Tanaka, M., Inokuchi, S., Makuuchi, H."Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma". Oncology Reports 28.5 (2012): 1531-1536.
Chicago
Okada, K., Kijima, H., Imaizumi, T., Hirabayashi, K., Matsuyama, M., Yazawa, N., Dowaki, S., Tobita, K., Ohtani, Y., Tanaka, M., Inokuchi, S., Makuuchi, H."Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma". Oncology Reports 28, no. 5 (2012): 1531-1536. https://doi.org/10.3892/or.2012.1971
Copy and paste a formatted citation
x
Spandidos Publications style
Okada K, Kijima H, Imaizumi T, Hirabayashi K, Matsuyama M, Yazawa N, Dowaki S, Tobita K, Ohtani Y, Tanaka M, Tanaka M, et al: Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma. Oncol Rep 28: 1531-1536, 2012.
APA
Okada, K., Kijima, H., Imaizumi, T., Hirabayashi, K., Matsuyama, M., Yazawa, N. ... Makuuchi, H. (2012). Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma. Oncology Reports, 28, 1531-1536. https://doi.org/10.3892/or.2012.1971
MLA
Okada, K., Kijima, H., Imaizumi, T., Hirabayashi, K., Matsuyama, M., Yazawa, N., Dowaki, S., Tobita, K., Ohtani, Y., Tanaka, M., Inokuchi, S., Makuuchi, H."Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma". Oncology Reports 28.5 (2012): 1531-1536.
Chicago
Okada, K., Kijima, H., Imaizumi, T., Hirabayashi, K., Matsuyama, M., Yazawa, N., Dowaki, S., Tobita, K., Ohtani, Y., Tanaka, M., Inokuchi, S., Makuuchi, H."Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma". Oncology Reports 28, no. 5 (2012): 1531-1536. https://doi.org/10.3892/or.2012.1971
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team